BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Influenza
,
Lung
,
Early pregnancy factor
,
Fluoxetine
,
PRKCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MAGE)-A1
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for MAGE)-A1
Explore Curated Studies Results
Literature
Most Relevant Literature
Avidity optimization of a MAGE-A1-specific TCR with somatic hypermutation.
Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TAT…
Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchosco…
MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patien…
MAGE-A1 promotes melanoma proliferation and migration through C-JUN activation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic…
A Phase 1/2, First-in-Human, Open-Label, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*0…
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and At…
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01…
Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transpl…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ